Amlexanox for Type 2 Diabetes and Obesity

Clinical trial NCT01842282 · TERMINATED

Trial details

NCT number: NCT01842282
Sponsor: University of Michigan
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Diabetes Mellitus Type 2 Non Alcoholic Fatty Liver Disease Obesity

Start date: 2013-07-19
Primary completion: 2014-02-25
Enrollment: 7

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.